The contemporary landscape of chemical research, novel psychoactive substances, and synthetic stimulants is currently undergoing a period of intense regulatory tracking and legal evolution. For laboratory researchers, chemical analysts, and cognitive enthusiasts operating across the Western hemisphere, a highly potent synthetic stimulant has become a central point of volatile discussion: 3′,4′-Methylenedioxy-α-pyrrolidinohexiophenone, commonly known as MDPHP. […]